Complete this form to register
February 28, 2017
01:00 - 03:00 PM
The Max Planck Institute of Experimental Medicine
- Seminar room A1-
RNAscope® technology is being routinely used for tissue-based gene expression analysis for target validation, pathobiology and biomarker development in every disease area. This technology, with its capacity to provide single-cell and single-RNA molecule sensitivity in the context of complex tissue microenvironments, is an ideal tool to complement technologies like IHC, qPCR or NGS.
Our recent advances in RNAscope® technology, now enables detection of any mRNA, short RNA targets and exon junctions. In this seminar we will discuss how RNA ISH has been successfully applied to various areas of research and will highlight the benefits of RNAscope® technology.
Our Senior Director of Scientific Affairs, Dr. Emily Park, will present the application of RNAscope® and BaseScope™ in Neuroscience research and will give an overview on:
- Detection, characterization, and (co-)localization of mRNAs in the central and peripheral nervous system
- Validation of target mRNA expression
- Validation of (cell type-specific) genetic modifications
- Detection of mRNA in the nervous system when no (reliable) antibodies are available
- Detection of long non-coding RNA (lncRNA)
- Visualization of neuronal activity and plasticity markers
In addition, Dr. Liane Wüstefeld, Institute of Clinical Neuroscience at the Max Planck Institute of Experimental Medicine, Göttingen will give a presentation: "First experience with RNAscope®"
We would also like to extend this invitation to your colleagues and other scientists in your organization who are using molecular methods for gene expression analysis and are interested in new RNA technologies.
Dr. Liane Wüstefeld,
Institute of Clinical Neuroscience at the Max Planck Institute of Experimental Medicine, Göttingen
Dr. Emily Park, Senior Director of Scientific Affairs
Advanced Cell Diagnostics, Inc.